Professor Coen Stehouwer, Professor of Internal Medicine and Chair of the Department of Internal Medicine, Maastricht University, The Netherlands.
Professor Coen Stehouwer currently is Professor of Internal Medicine and Chair of the Department of Internal Medicine at Maastricht University in the Netherlands.
He is an internationally recognized clinician-scientist in the field of microcirculatory as well as large artery research, notably in the context of cardiovascular complications of diabetes and the metabolic syndrome.
Since 1990, the work of Professor Stehouwer and his group has led to 69 completed PhD theses, and more than 750 peer-reviewed papers in international journals.
His work is well-recognized as shown by a Hirsh index of 96 (Web of Science); >36,000 citations; several awards, such as the Dr. F. Gerritzen Award for excellent diabetes research (Dutch Diabetes Research Foundation, 1993); the Castelli-Pedroli Award for excellent research into the complications of diabetes (European Association for the Study of Diabetes, 2005); the Dutch Society of Vascular Medicine Career Award (2007); and the Ruitenga Van Swieten honorary professorship of the University of Amsterdam (2009); as well as many invited lectures at (inter)national meetings, such as those of the European Conference on Microcirculation, the World Congress for Microcirculation, the European Society for the Study of Diabetes, the American Diabetes Association, the European Society for Cardiology, and the American Heart Association.
His research programme focuses on the elucidation of how metabolic changes in (pre)diabetes and the metabolic syndrome cause micro- and macrovascular disease. A key element of the programme is to combine epidemiology, clinical physiology and experimental approaches, in the conviction that these approaches should complement and mutually inspire each other. He is one of the principal investigators of the well-known Hoorn Study (since 1992). He also obtained national and European funding (M€ 16) for, and is the initiator and Scientific Director of, the Maastricht Study (started 2010), which combines very detailed phenotyping (with a focus on cardiac, large artery and brain, retina and skin microcirculatory function and structure) with an ‘omics’ approach in 5000 individuals with and 3000 without type 2 diabetes to elucidate how diabetes leads not only to classic complications but also to so-called emerging complications such as cognitive dysfunction, mood disorders, liver disease, musculoskeletal disease, pulmonary disease, sleep-disordered breathing, and infectious diseases.
C.D.A (Coen) Stehouwer (born Rotterdam, 1960) obtained an MD at the Erasmus University in Rotterdam (1985; cum laude). He was registered as internist in 1990 and obtained a PhD in 1992 (Vrije Universiteit Medical Centre, Amsterdam). He received postgraduate training in epidemiology and molecular biology.
He was appointed professor of medicine and vice-chair of the Department of Medicine in 2000 at the Vrije Universiteit in Amsterdam). In 2004, he accepted a position as professor of medicine and chair of the department of medicine at the University of Maastricht.